湖北日报讯 （记者文凯）8月7日，广东东阳光药业股份有限公司（以下简称“东阳光药”，股票代码06887.HK）正式登陆香港联交所主板。作为首单H股吸收合并私有化加介绍上市的案例，东阳光药通过吸收合并港股上市子公司东阳光长江药业实现整体上市。合并后，东阳光药深厚的研发技术积淀和全方位的国际化布局，将被纳入上市公司体系。东阳光药董事长张英俊在上市仪式致辞中表示，本次一体化的成功，公司将加速整合优质资源...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.